孕妇与儿童管理:聚焦预防乙肝母婴传播
本文综述了乙型肝炎病毒(HBV)母婴传播的预防与管理。普遍新生儿免疫预防有效性超过90%,但母婴传播仍是慢性HBV感染的主要原因,母亲HBeAg阳性和高病毒载量是最重要的危险因素。近年研究显示妊娠晚期短期抗病毒治疗可高效减少90%的疫苗失败,产后需监测母亲转氨酶,并应在1岁时对高危儿童检测HBsAg和抗-HB以识别慢性感染。
要点
- 母亲HBeAg阳性和高病毒载量是HBV母婴传播最重要的危险因素。
- 妊娠晚期短期抗病毒治疗可高效减少90%的疫苗失败。
- 高危儿童应在1岁时检测HBsAg和抗-HB以识别慢性HBV感染。
核心结论
- 普遍新生儿免疫预防有效性超过90%,但母婴传播仍是慢性HBV感染的主要原因。
- 妊娠晚期短期抗病毒治疗可高效减少90%的疫苗失败。
研究设计与样本
- 本文为综述,总结HBV母婴传播预防与管理的相关证据。
主要发现
- 母亲HBeAg阳性和高病毒载量是母婴传播最重要的危险因素。
- 妊娠晚期短期抗病毒治疗可高效减少90%的疫苗失败。
- 产后需监测母亲转氨酶升高。
- 多数慢性HBV感染儿童处于免疫耐受期。
关键数值与推荐
- 应在1岁时对高危儿童检测HBsAg和抗-HB以识别慢性HBV感染。
- 儿童抗病毒治疗目标是减轻肝损伤严重程度、实现HBeAg血清学转换、预防肝纤维化和肝癌。
临床怎么用
- 对HBeAg阳性或高病毒载量的孕妇应考虑妊娠晚期短期抗病毒治疗以预防母婴传播。
- 产后监测母亲转氨酶,并在1岁时对高危儿童检测HBsAg和抗-HB。
局限性
- 母亲和儿童的长期结局尚需进一步研究。
- 儿童抗病毒治疗的最佳指征和药物方案仍在研究中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hepatitis B virus (HBV) immunization has been effectively preventing chronic HBV infection with >90% efficacy in countries with universal neonatal immunization. Perinatal mother-to-infant transmission of HBV remains the major cause of chronic HBV infection despite immunization. Maternal hepatitis B e-antigen (HBeAg) and high viral load have been noted to be the most important risk factors for transmission. In recent years, short-term antiviral therapy for pregnant women in the third trimester has been shown to be highly effective in reducing 90% of vaccine failure in children. It is important to monitor maternal aminotransferase elevations postpartum. Long-term outcome of mothers and children is needed and awaits further investigations. Despite the above-mentioned preventive measures, it is also important to monitor high-risk children at 1 year of age with hepatitis B surface antigen and anti-hepatitis B to identify those with chronic HBV infection. Most of the children with chronic HBV infection were in the immune-tolerant phase. The goals for antiviral treatment in children are to reduce severity of liver injury, achieve HBeAg seroconversion, and prevent development of liver fibrosis and cancer. Studies on antiviral therapy are undergoing to elucidate the optimal indication and drug treatment for children. The ideal future goal of treatment is to eradicate chronic HBV infection globally.
引用
- Chen HL, Wen WH, Chang MH, et al. Management of Pregnant Women and Children: Focusing on Preventing Mother-to-Infant Transmission. J Infect Dis. 2017. PMID: 29156049. doi:10.1093/infdis/jix429
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。